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Introduction
Outside the protection of the geomagnetic field, astronauts and other living 
organisms are constantly exposed to space radiation that consists of energetic 
protons and other heavier charged particles. Whether spaceflight factors, 
microgravity in particular, have effects on cellular responses to DNA damage 
induced by exposure to radiation or cytotoxic chemicals is still unknown, as is 
their impact on the radiation risks for astronauts and on the mutation rate in 
microorganisms. 
Although possible synergistic effects of space radiation and other spaceflight 
factors have been investigated since the early days of the human space program, 
the published results were mostly conflicting and inconsistent. To investigate 
effects of spaceflight on cellular responses to DNA damages, human fibroblast 
cells flown to the International Space Station (ISS) were treated with bleomycin 
for three hours in the true microgravity environment, which induced DNA 
damages including double-strand breaks (DSB) similar to the ionizing radiation. 
Damages in the DNA were measured by the phosphorylation of a histone protein 
H2AX (g-H2AX), which showed slightly more foci in the cells on ISS than in 
the ground control. The expression of genes involved in DNA damage response 
was also analyzed using the PCR array. Although a number of the genes, 
including CDKN1A and PCNA, were significantly altered in the cells after 
bleomycin treatment, no significant difference in the expression profile of DNA 
damage response genes was found between the flight and ground samples. At the 
time of the bleomycin treatment, the cells on the ISS were found to be 
proliferating faster than the ground control as measured by the percentage of 
cells containing positive Ki-67 signals. Our results suggested that the difference 
in g-H2AX focus counts between flight and ground was due to the faster growth 
rate of the cells in space, but spaceflight did not affect initial transcriptional 
responses of the DNA damage response genes to bleomycin treatment. 
Objectives
Investigate cellular responses to bleomycin-
induced DNA damage in G1 human fibroblast cells 
in space.
Experimental Design
Results
PCRarray Study - DNA Damage Signaling
When comparing bleomycin treated to placebo treated samples, four 
genes whose expressions were significantly changed in both ground 
and flight samples after bleomycin treatment. This result is in 
agreement of our previous ground study results (manuscript in 
preparation). 
Conclusions
• Space flight had little effects on the cellular response to 
bleomycin-induced DNA damages in confluent human fibroblast 
cells as measured by the pattern of g-H2AX.
• Spaceflight did not affect the response of the DNA damage 
response genes to bleomycin treatment in confluent human 
fibroblast cells.
• The slight difference in the g-H2AX focus count between the 
flown and ground cells after bleomycin treatment was likely due to 
the faster growth rate of the cells in space.
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Experimental Details: Confluent human 
fibroblast AG1522 cells in Biocells were 
treated with placebo or 1.0 mg/ml of 
Bleomycin for 3 hours, and then washed 
with PBS and fixed with formaldehyde or 
RNALater II. The cells were kept at 4C until 
returning to Johnson Space Centr (JSC). 
Ground experiments were performed 
exactly the same way as in space, but with a 
6 hour offset from the flight schedule at 
Kennedy Space Center (KSC). 
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Analysis: Cells fixed with formaldehyde were subjected to 
immunofluorescence staining to access cellular proliferation (Ki-67) and the 
extent of DNA damages (gH2Ax).
Total RNA isolated from RNALater II fixed cells was subjected to RT-PCR , 
using  RT2 Profiler PCR Array Human DNA Damage Signaling Pathway (SA 
Biosciences, Qiagen) and Bio-Rad CFX96 Touch™ Real-Time PCR 
Detection System.
Type I Nucleus: strong pan 
nuclear staining
Type II Nucleus: 
with identifiable 
but not countable 
foci.
Type III Nucleus: with distinct countable foci
Examples of g-H2AX staining patterns in confluent AG1522 
fibroblast cells after three hours treatment of bleomycin.
Quantification of DNA damage by counting of gH2Ax staining 
patterns (Type I, II, & III) showed no significant differences 
between the flown and ground cells.
Quantification of DNA damage by counting of gH2Ax foci per 
nucleus (in Type III only) showed that cells in space flight were 
more sensitive to bleomycin treatment. Insert shows that there 
were slightly more proliferating cells in the flight population on 
Day 3.
Experimental Design (continued) Results (Continued)
Control ground experiments confirmed that cells with higher 
proliferating population were more sensitive to bleomycin 
treatment. Shown below are examples of subconfluent cells (> 90% 
Ki-67 positive) were slightly more sensitive to bleomycin treatment 
of the same concentration.
Bleomycin treated vs placebo
Genes
Ground Flight
BBC3
CDKN1A
PPM1D
PCNA
Note: p < 0.05;  Cutoff in fold change is set at 1.3
Top regulated canonical pathways for bleomycin treated 
samples in flight and ground.
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